Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
Hector Chinoy, PhD, MBBS, MSc, FRCP
The University of Manchester
Manchester, United Kingdom
Disclosure(s): AstraZeneca: Advisor or Review Panel Member (Ongoing); Biogen: Consultant (Ongoing); Eli Lilly: Grant/Research Support (Ongoing); GlaxoSmithKlein(GSK): Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Novartis: Consultant (Ongoing); Orphazyme: Consultant (Ongoing); Pfizer: Advisor or Review Panel Member (Ongoing); UCB: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Lisa Christopher-Stine, MD, MPH
Johns Hopkins University
Baltimore, MD, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Elie Naddaf, MD
Mayo Clinic
Rochester, MN, United States
Disclosure(s): UCB Pharmaceutical: Consultant (Terminated)
Myositis is a rare disease, and the care of these patients can be challenging. This session will discuss various clinical observations helpful in the evaluation of patients with myositis and include practical tips for both diagnosis and management.
Speaker: Hector Chinoy, PhD, MBBS, MSc, FRCP – The University of Manchester
Speaker: Elie Naddaf, MD – Mayo Clinic
Speaker: Lisa Christopher-Stine, MD, MPH – Johns Hopkins University